Brief: Morepen Laboratories Says Received USFDA Approval For Anti-Allergy Drug Fexofinadine Hydrochloride
03/12/2021 06:39
Morepen Laboratories Ltd MORL.NS :
* MOREPEN LABORATORIES SAYS RECEIVED USFDA APPROVAL FOR
ANTI-ALLERGY DRUG FEXOFINADINE HYDROCHLORIDE
Source text for Eikon: ID:nBSE61GffL
Further company coverage: MORL.NS
Recent news on Morepen Laboratories
See all newsBrief: Morepen Laboratories Says High Court Quashes Notice Seeking Recovery Of 1.18 Billion Rupees
India's Morepen Laboratories gains on U.S. FDA submission for Sitagliptin tablets
Brief: Morepen Laboratories Submits First U.S. ANDA For Sitagliptin Tablets USP In Three Strengths
Brief: Morepen Laboratories Ltd June-Quarter Consol Net Profit 563.5 Million Rupees
India's Morepen Laboratories slips after quarterly profit fall